Selectivity is a comparison across measured targets. The original experimental context matters because a different species or assay may produce a different response profile. An absence of an effect at one tested condition is not proof that it can never occur. Retain the actual measurement and comparator when summarizing the evidence.
Representative product imagery. Verify the physical label and lot documentation on receipt.
Growth Signaling
Ipamorelin
In stock·Ships in 1–2 business days
Ipamorelin research material supplied with batch-level documentation. Each unit is labeled with a traceable lot code and links to its corresponding analytical report.
Select size2 options
Select pack sizeSave 18% on kits
1 × 5 mg$33.99
In stockSelected size 5 mgSC-IP5-005
Transparent volume pricing10-vial peptide kits save 18%.
Secure checkout US & EU dispatch
Research use only acknowledgment required at checkout
Published report · Lot 2025290
Reports describe the tested lot. Match the lot on your label before interpreting results.
Compound context
What researchers study
Ipamorelin peptide is a synthetic growth hormone secretagogue investigated through ghrelin receptor and endocrine research. This listing is for a laboratory reference, with available quantities shown beside the purchase controls. The intended assay should determine which chemical identity and documentation are required. It is not a product supplied for a personal hormone or performance regimen.
The original pharmacology publication investigated selectivity within defined experimental systems. A claim of selectivity is always tied to the targets and conditions examined. It doesn't establish that every possible biological effect has been excluded. The distinction is especially relevant when a cell assay is discussed alongside an endocrine study in an intact organism.
Comparing ipamorelin with a GHRH analog requires attention to the different receptor pathways. A common downstream hormone marker does not make the experiments equivalent. Sampling time and background signaling can influence the apparent difference. State whether the question concerns receptor response, secretion or another endpoint before selecting the comparison conditions.
Scope limitMatch the peptide's identity and supplied form to its current batch report. Research use excludes human dosing instructions or therapeutic advice. Clinical adverse event information cannot be replaced by a supplier's purity measurement.
Serenity Compounds is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.
Common laboratory focus
Sermorelin is associated with the GHRH receptor pathway, while this secretagogue is studied through a different receptor system. Both can appear in growth hormone discussions without having the same molecular mechanism. A comparison should preserve that distinction rather than treating the names as alternative quantities of one substance.
Reference ligands and vehicle measurements help establish the response range and background. An independent viability readout can reveal nonspecific interference when cells are involved. The analytical identity of the tested lot should remain connected to those results. A consistent signal alone doesn't establish pharmaceutical equivalence or a human administration schedule.
Quality documentation
Know what your laboratory receives.
Batch records are published for transparency and should be independently reviewed by qualified research personnel.
Current certificateIpamorelin · Lot 2025290Liquilabs s.r.o.View report
- Tamper-evident packaging
- Lot and SKU traceability
- Independent analytical review
Continue exploring
